Back to top
more

Vital Farms (VITL)

(Delayed Data from NSDQ)

$35.27 USD

35.27
640,874

-1.93 (-5.19%)

Updated Aug 1, 2025 04:00 PM ET

After-Market: $35.28 +0.01 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 22% (193 out of 246)

Industry: Food - Miscellaneous

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Are Consumer Staples Stocks Lagging British American Tobacco (BTI) This Year?

by Zacks Equity Research

Here is how British American Tobacco (BTI) and Vital Farms (VITL) have performed compared to their sector so far this year.

Zacks Equity Research

Nu Skin (NUS) Trims FY24 View Despite Q2 Earnings Beat

by Zacks Equity Research

Nu Skin's (NUS) second-quarter 2024 results reflect lower earnings and net sales amid a dynamic macro-environment. Management lowers the 2024 guidance range.

Zacks Equity Research

Monster Beverage (MNST) Stock Down on Q2 Earnings & Sales Miss

by Zacks Equity Research

Monster Beverage (MNST) posts soft second-quarter 2024 results. Its Monster Energy Drinks segment's sales rise 3.3% year over year.

Zacks Equity Research

Wall Street Analysts See Vital Farms (VITL) as a Buy: Should You Invest?

by Zacks Equity Research

According to the average brokerage recommendation (ABR), one should invest in Vital Farms (VITL). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Zacks Equity Research

Vital Farms (VITL) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Vital Farms (VITL) delivered earnings and revenue surprises of 71.43% and 2.53%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Inter Parfums (IPAR) Q2 Earnings Top, Sales Up on Robust Demand

by Zacks Equity Research

Inter Parfums' (IPAR) second-quarter 2024 results reflect higher sales and earnings on continued momentum in the fragrance market and strength in its legacy and new brands.

Zacks Equity Research

Sally Beauty (SBH) Q3 Earnings in the Cards: Things to Note

by Zacks Equity Research

Sally Beauty's (SBH) third-quarter fiscal 2024 performance will likely reflect the adverse impact of a decline in customer traffic and inflationary pressures.

Zacks Equity Research

Grocery Outlet's (GO) Q2 Earnings Beat, Comps Jump 2.9% Y/Y

by Zacks Equity Research

Grocery Outlet's (GO) second-quarter results reflect a comparable store sales increase of 2.9%. Management anticipates comparable store sales growth of 3.5% for 2024.

Zacks Equity Research

B&G Foods (BGS) Q2 Earnings Meet Estimates, Unit Volumes Dip

by Zacks Equity Research

B&G Foods' (BGS) second-quarter 2024 results reflect lower earnings and sales amid demand challenges in the consumer-packaged food space.

Zacks Equity Research

Energizer (ENR) Q3 Earnings Beat Estimate, Organic Sales Up Y/Y

by Zacks Equity Research

Energizer's (ENR) third-quarter earnings rise y/y. Despite facing challenges, the company is concentrating on cost-saving measures and pursuing strategic initiatives to strengthen its position.

Zacks Equity Research

Molson Coors (TAP) Gains as Q2 Earnings & Sales Beat Estimates

by Zacks Equity Research

Molson Coors' (TAP) Q2 results reflect gains from favorable pricing and the U.S. shipment timing, offset by a decline in the contract brewing volumes.

Zacks Equity Research

Vital Farms (VITL) Q2 Earnings on the Deck: Key Factors to Note

by Zacks Equity Research

Vital Farms (VITL) is poised for a robust second-quarter performance, driven by its strategic expansion, operational efficiencies and ability to capitalize on market trends.

Zacks Equity Research

TreeHouse Foods (THS) Q2 Earnings Beat Estimates, Sales Drop

by Zacks Equity Research

TreeHouse Foods' (THS) Q2 results reflect declines in sales and earnings on lower volumes. Management lowers the upper end of its adjusted EBITDA guidance for 2024.

Zacks Equity Research

Medifast (MED) Q2 Earnings Beat Estimates, Revenues Fall Y/Y

by Zacks Equity Research

Medifast's (MED) Q2 results highlight the challenges of poor customer acquisition. However, the company is focusing strategically on medically supported weight loss, indicating potential for growth.

Zacks Equity Research

Zacks.com featured highlights include Vital Farms CSW Industrials, Atmos, NiSource and Kirby

by Zacks Equity Research

Vital Farms CSW Industrials, Atmos, NiSource and Kirby have been highlighted in this Screen of The Week article.

Zacks Equity Research

J&J Snack Foods (JJSF) Misses Q3 Earnings and Revenue Estimates

by Zacks Equity Research

J&J Snack Foods (JJSF) delivered earnings and revenue surprises of -1.49% and 0.40%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Aparajita Dutta headshot

5 Low-Leverage Stocks to Buy Amid Disappointing Job Data

by Aparajita Dutta

The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find. You may buy VITL, CSWI, ATO, NI & KEX.

Zacks Equity Research

Inter Parfums (IPAR) Q2 Earnings in the Cards: Things to Note

by Zacks Equity Research

Inter Parfums' (IPAR) second-quarter performance is likely to reflect strong momentum in the fragrance market, supported by robust sales from its new licenses. High SG&A costs are a threat.

Zacks Equity Research

Monster Beverage's (MNST) Q2 Earnings Coming Up: Things to Note

by Zacks Equity Research

Monster Beverage's (MNST) second-quarter 2024 results are likely to reflect gains from strength in its energy drinks category and product launches.

Zacks Equity Research

B&G Foods' (BGS) Q2 Earnings in the Cards: Factors to Watch

by Zacks Equity Research

B&G Foods' (BGS) Q2 results are likely to reflect the impacts of category-wide challenges across the food industry and high SG&A costs.

Zacks Equity Research

Can Molson Coors' (TAP) Strategies Outrun Inflation Woes in Q2?

by Zacks Equity Research

Molson Coors' (TAP) strategic investments and premiumization efforts drive robust growth amid industry challenges and inflationary pressures. Let us see how the Q2 performance is likely to have been.

Zacks Equity Research

AB InBev (BUD) Tops on Q2 Earnings & Revenues on Robust Demand

by Zacks Equity Research

AB InBev's (BUD) Q2 results reflect strong consumer demand for its megabrands, double-digit organic EBITDA growth and continued optimization of its business.

Zacks Equity Research

Post Holdings (POST) Tops Q3 Earnings, Raises FY24 Outlook

by Zacks Equity Research

Post Holdings (POST) fiscal third-quarter results reflect sales growth in Post Consumer Brands and Weetabix, counterbalanced by declines in the Foodservice and Refrigerated Retail segments.

Zacks Equity Research

Implied Volatility Surging for Vital Farms (VITL) Stock Options

by Zacks Equity Research

Investors need to pay close attention to Vital Farms (VITL) stock based on the movements in the options market lately.

Zacks Equity Research

Clorox (CLX) Q4 Earnings Beat Estimates, Gross Margin Expands

by Zacks Equity Research

Clorox's (CLX) fiscal 2025 gross margin is expected to improve by around 100 basis points, driven by comprehensive margin management efforts.